Figure 6.
Analysis of the XL-EDA-ID patient's T cells. (A) TCR Vβ repertoire analysis of the patient's CD4+ and CD8+ cells. The patient's PBMCs were stained for the TCR Vβ panel and CD4 or CD8 as described by Kobayashi et al.29 The healthy controls consisted of children 1 to 10 years old (n = 10). The values are shown as mean ± SD. (B) Naive and memory phenotypes of the patient's T cells. PBMCs from the patient and control were stained with NEMO, CCR7, CD45RA, and CD4 or CD8. Cells gated on NEMOlow or NEMOnormal of CD4 or CD8 are shown. (C) Reduced IFN-γ production of NEMOlow T cells. The patient and control PBMCs were stimulated with PMA/ionomycin/monensin for 6 hours and stained for intracellular IFN-γ along with NEMO and CD4 or CD8. Cells gated on CD4 or CD8 are shown. (D) Proliferation assay of PBMCs stimulated by an anti-CD3 mAb plus an anti-CD28 mAb. PBMCs from the patient or healthy controls were stimulated for 48 hours with an anti-CD3 mAb, an anti-CD3 mAb plus the anti-CD28 mAb ± IL-2 (100 IU/mL), PHA, or PMA/ionomycin. Data are shown as mean ± SD. (E) Reduced production of IL-2 and IFN-γ by anti-CD3 mAb plus anti-CD28 mAb. PBMCs from the patient or healthy controls were stimulated for 48 hours by the anti-CD3 mAb, anti-CD3 mAb plus anti-CD28 mAb, or PMA/ionomycin, and the supernatants were harvested for ELISA assays.